Xenotransplantation: Application of disease resistance

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 12, 1999, Pages 1009-1012

  Mueller, Yvonne M ^a   Davenport, Colleen ^a   Ildstad, Suzanne T ^a,b  

^a University of Louisville   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Bone marrow transplantation; Disease resistance; Donor shortage; Haematopoietic stem cells; Xenotransplantation

Indexed keywords

BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; DISEASE RESISTANCE; DONOR; GENETIC ENGINEERING; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSUPPRESSIVE TREATMENT; MORBIDITY; MORTALITY; NONHUMAN; XENOTRANSPLANTATION;

ANIMALS; HUMANS; IMMUNITY, NATURAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033405135     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03182.x     Document Type: Conference Paper

References (33)

1. 1. Squinto S, Fodor W. Engineering of xenografts to provide organs for human transplantation. In: Cooper D, Kemp E, Platt J, White DJG (eds). Xenotransplantation: The Transplantation of Organs and Tissues Between Species. Springer-Verlag, Berlin. 1997.
2. 2. Reemtsma K, McCracken B, Schlegel J, Pearl M. Heterotransplantation of the kidney: Two clinical experiences. Science 1962; 143: 700-2.
3. 3. Reemtsma K, McCracken B, Schlegel J, Pearl M, DeWitt C, Creech O. Reversal of early graft rejection after renal heterotransplantation in man. JAMA 1964; 187: 691-6.
4. 4. Reemtsma K, McCracken B, Schlegel J, Pearl M, Pearce C, DeWitt C. Renal heterotransplantation in man. Ann. Surg. 1964; 160: 384-410.
5. 5. Starzl TE, Marchioro T, Peters G, Kirkpatrick C, Wilson W, Porter K. Renal heterotransplantation from baboon to man: Experience with 6 cases. Transplantation 1963; 2: 752-76.
6. 6. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254: 3321-9.
7. 7. Walpoth B, Nehlsen Cannarella S, Bailey L. Xenotransplantation: Extended indications for pediatric cardiac transplantation. Transplant. Proc: 1986; 18: 43-4.
8. 8. Starzl TE, Fung J, Tzakis A et al. Baboon-to-human liver transplantation. Lancet 1993; 341: 65-71.
9. 9. Starzl TE, Tzakis A, Fung J, Todo S, Marino IR, Demetris AJ. Human liver transplantation. Xeno Today 1993; 1: 4-7.
10. 10. Congdon C, Lorenz E. Humoral factor in irradiation protection: Modification of lethal irradiation injury in mice by injection of rat bone marrow. Am. J. Physiol. 1954; 176: 297-301.
11. 11. Nowaell P, Cole L, Habermeyer J, Roan P. Growth and function of rat marrow cells in X-irradiated mice. Cancer Res. 1955; 16: 258-62.
12. 12. Ford C, Hamerton J, Barnes D, Loutit J. Cytological identification of radiation chimeras. Nature 1956; 177: 452-4.
13. 13. Thomas E, Lochte H, Lu W, Ferrebee J. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 1957; 157: 491-6.
14. 14. Ildstad ST, Wren SM, Boggs SS, Hronakes ML, Vecchini F, Van den Brink MR. Cross-species bone marrow transplantation: Evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat → mouse). J. Exp. Med. 1991; 174: 467-78.
15. 15. Exner BG, Neipp M, Ildstad ST. Baboon bone marrow transplantation in humans: Application of cross-species disease resistance. World J. Surg. 1997; 21: 962-7.
16. 16. Shortman K, Egerton M. Spangrude GJ, Scollay R. The generation and fate of thymocytes. Semin. Immunol. 1990; 2: 3-12.
17. 17. Von Boehmer H. The developmental biology of T lymphocytes. Annu. Rev. Immunol. 1988; 6: 309-26.
18. 18. MacDonald HR, Howe RC, Pedrazzini T et al. T-Cell lineages, repertoire selection and tolerance induction. Immunol. Rev. 1988; 104: 157-82.
19. 19. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 1992; 10: 267-93.
20. 20. Sprent J, Lo D, Gao EK, Ron Y. T cell selection in the thymus. Immunol. Rev. 1988; 101: 173-90.
21. 21. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 1985; 162: 231-44.
22. 22. Hodes RJ, Singer A. Cellular and genetic control of antibody responses in vitro. I. Cellular requirements for the generation of genetically controlled primary IgM responses to soluble antigens. Eur. J. Immunol. 1977; 7: 892-7.
23. 23. Sykes M. Chimerism and central tolerance. Curr. Opin. Immunol. 1996; 8: 694-703.
24. 24. Zinkernagel RM, Althage A, Callahan G, Welsh RMJ. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J. Immunol. 1980; 124: 2356-65.
25. 25. Ruedi E, Sykes M, Ildstad ST et al. Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2 → P1) irradiation chimeras. Cell. Immunol. 1989; 121: 185-95.
26. 26. Ildstad ST, Boggs SS, Vecchini F et al. Mixed xenogeneic chimeras (rat + mouse to mouse). Evidence of rat stem cell engraftment, strain-specific transplantation tolerance, and skin-specific antigens. Transplantation 1992; 53: 815-22.
27. 27. Ricordi C, Zeng Y, Carroll PB et al. Islet xenografts in fully xenogeneic (rat →mouse) chimeras: Evidence for normal regulation of function in a xenogeneic mouse environment. Surgery 1992; 112: 327-32.
28. 28. Colson Y, Zadach K, Ildstad ST. Mixed xenogeneic bone marrow chimerism (mouse + rat →mouse) induces donor-specific tolerance for cardiac grafts across a species barrier. Surg. Forum 1993; 44: 294-6.
29. 29. Colson YL, Zadach K, Ildstad S. Mixed xenogeneic chimerism (mouse + rat →mouse) induces cellular and humoral tolerance for primarily vascularized cardiac allografts. Surg. Forum 1995; 46: 241-3.
30. 30. Colson YL, Tripp RA, Doherty PC et al. Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: Functional restriction to host MHC. J. Immunol. 1998; 160: 3790-6.
31. 31. Neipp M, Exner BG, Ildstad ST. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance. Transplantation 1998; 66: 969-75.
32. 32. Michaels MG, Lanford R, Demetris AJ et al. Lack of susceptibility of baboons to infection with hepatitis B virus. Transplantation 1996; 61: 350-1.
33. 33. Allan JS, Ray P, Broussard S et al. Infection of baboons with simian/human immunodeficiency viruses. J. AIDS Hum. Retrovirol. 1995: 9: 429-41.